CN1033000A - 营养品食物和药品的镁添加剂 - Google Patents

营养品食物和药品的镁添加剂 Download PDF

Info

Publication number: CN1033000A
Authority: CN; China
Prior art keywords: magnesium; additive; citrate; taste; acid
Prior art date: 1987-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN88107933A

Other languages

English (en)

Chinese (zh)

Inventor

卡尔·约翰·内德兰

玛丽·安·克莱皮

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Collett-Marwell Hauge AS

Original Assignee

Collett-Marwell Hauge AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-28

Filing date

1988-09-27

Publication date

1989-05-24

1988-09-27 Application filed by Collett-Marwell Hauge AS filed Critical Collett-Marwell Hauge AS

1989-05-24 Publication of CN1033000A publication Critical patent/CN1033000A/zh

Status Pending legal-status Critical Current

Links

FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 26
229910052749 magnesium Inorganic materials 0.000 title claims abstract description 26
239000011777 magnesium Substances 0.000 title claims abstract description 26
239000000654 additive Substances 0.000 title claims abstract description 19
230000000996 additive effect Effects 0.000 title claims abstract description 19
239000003814 drug Substances 0.000 title claims abstract description 7
235000015097 nutrients Nutrition 0.000 title description 2
229940091250 magnesium supplement Drugs 0.000 claims abstract description 25
PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims abstract description 20
229960005336 magnesium citrate Drugs 0.000 claims abstract description 19
239000004337 magnesium citrate Substances 0.000 claims abstract description 19
235000002538 magnesium citrate Nutrition 0.000 claims abstract description 19
239000002253 acid Substances 0.000 claims abstract description 17
OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 claims abstract description 17
239000000626 magnesium lactate Substances 0.000 claims abstract description 17
229960004658 magnesium lactate Drugs 0.000 claims abstract description 17
235000015229 magnesium lactate Nutrition 0.000 claims abstract description 17
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims abstract description 10
239000000347 magnesium hydroxide Substances 0.000 claims abstract description 10
229910001862 magnesium hydroxide Inorganic materials 0.000 claims abstract description 10
150000001720 carbohydrates Chemical class 0.000 claims abstract description 6
235000013305 food Nutrition 0.000 claims abstract description 4
HZTVQLXIRHEMMB-UHFFFAOYSA-H trimagnesium 2-hydroxypropane-1,2,3-tricarboxylate hydrate Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Mg+2].O.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Mg+2].[Mg+2] HZTVQLXIRHEMMB-UHFFFAOYSA-H 0.000 claims abstract description 3
159000000003 magnesium salts Chemical class 0.000 claims description 6
238000005469 granulation Methods 0.000 description 21
230000003179 granulation Effects 0.000 description 21
235000001055 magnesium Nutrition 0.000 description 19
239000002245 particle Substances 0.000 description 16
150000003839 salts Chemical group 0.000 description 16
235000019640 taste Nutrition 0.000 description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
239000007788 liquid Substances 0.000 description 10
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 9
235000019658 bitter taste Nutrition 0.000 description 7
238000006386 neutralization reaction Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 6
210000000697 sensory organ Anatomy 0.000 description 6
150000001875 compounds Chemical class 0.000 description 5
239000000796 flavoring agent Substances 0.000 description 5
235000019634 flavors Nutrition 0.000 description 5
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
230000001458 anti-acid effect Effects 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
230000000694 effects Effects 0.000 description 4
150000002681 magnesium compounds Chemical class 0.000 description 4
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
206010012735 Diarrhoea Diseases 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000003825 pressing Methods 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
208000008167 Magnesium Deficiency Diseases 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
208000025371 Taste disease Diseases 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000008141 laxative Substances 0.000 description 2
229940125722 laxative agent Drugs 0.000 description 2
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
239000001095 magnesium carbonate Substances 0.000 description 2
229910000021 magnesium carbonate Inorganic materials 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
235000004764 magnesium deficiency Nutrition 0.000 description 2
239000000395 magnesium oxide Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
235000019656 metallic taste Nutrition 0.000 description 2
238000000034 method Methods 0.000 description 2
230000000116 mitigating effect Effects 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
235000012976 tarts Nutrition 0.000 description 2
208000004998 Abdominal Pain Diseases 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
206010010774 Constipation Diseases 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
206010013911 Dysgeusia Diseases 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
206010028347 Muscle twitching Diseases 0.000 description 1
VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000010513 Stupor Diseases 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
230000006793 arrhythmia Effects 0.000 description 1
206010003119 arrhythmia Diseases 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
208000015114 central nervous system disease Diseases 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
238000001631 haemodialysis Methods 0.000 description 1
230000000322 hemodialysis Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000000302 ischemic effect Effects 0.000 description 1
230000002475 laxative effect Effects 0.000 description 1
229940031958 magnesium carbonate hydroxide Drugs 0.000 description 1
QWLHYYKDLOVBNV-UHFFFAOYSA-L magnesium orotate Chemical compound [Mg+2].[O-]C(=O)C1=CC(=O)NC(=O)N1.[O-]C(=O)C1=CC(=O)NC(=O)N1 QWLHYYKDLOVBNV-UHFFFAOYSA-L 0.000 description 1
229960000407 magnesium orotate Drugs 0.000 description 1
GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
239000004137 magnesium phosphate Substances 0.000 description 1
229960002261 magnesium phosphate Drugs 0.000 description 1
229910000157 magnesium phosphate Inorganic materials 0.000 description 1
235000010994 magnesium phosphates Nutrition 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
NFFJLMKHRCXLJO-UHFFFAOYSA-L magnesium;2-aminobutanedioate Chemical compound [Mg+2].[O-]C(=O)C(N)CC([O-])=O NFFJLMKHRCXLJO-UHFFFAOYSA-L 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
FJQXCDYVZAHXNS-UHFFFAOYSA-N methadone hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 FJQXCDYVZAHXNS-UHFFFAOYSA-N 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
108010048734 sclerotin Proteins 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Inorganic Chemistry (AREA)
Neurology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Fodder In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)

CN88107933A 1987-09-28 1988-09-27 营养品食物和药品的镁添加剂 Pending CN1033000A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NO874067		1987-09-28
NO874067A NO168563C (no)	1987-09-28	1987-09-28	Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv

Publications (1)

Publication Number	Publication Date
CN1033000A true CN1033000A (zh)	1989-05-24

Family

ID=19890268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN88107933A Pending CN1033000A (zh)	1987-09-28	1988-09-27	营养品食物和药品的镁添加剂

Country Status (16)

Country	Link
US (1)	US4959222A (2)
JP (1)	JPH01108958A (2)
KR (1)	KR920003525B1 (2)
CN (1)	CN1033000A (2)
BE (1)	BE1003302A3 (2)
DE (1)	DE3832638A1 (2)
DK (1)	DK169605B1 (2)
ES (1)	ES2008604A6 (2)
FI (1)	FI98193C (2)
FR (1)	FR2620907B1 (2)
GB (1)	GB2210243B (2)
IT (1)	IT1225239B (2)
LU (1)	LU87348A1 (2)
NL (1)	NL192500C (2)
NO (1)	NO168563C (2)
SE (1)	SE501114C2 (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1074265C (zh) *	1999-03-19	2001-11-07	王晓忠	制备冻腐竹的方法
CN100475062C (zh) *	2001-09-19	2009-04-08	丸尾钙株式会社	食品添加剂浆状组合物和粉末组合物、以及含有该食品添加剂组合物的食品组合物

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01312871A (ja) *	1988-06-10	1989-12-18	Omron Tateisi Electron Co	スリット光用半導体発光ダイオード
DE4201504C2 (de) *	1992-01-21	1997-04-30	Protina Chemische Ges Mbh	Magnesiumpräparat
US5962030A (en)	1997-03-07	1999-10-05	Akesis Pharmaceuticals, Inc.	Dietary supplement and method of treatment for diabetic control
US6162464A (en) *	1997-03-31	2000-12-19	Inkine Pharmaceutical, Inc.	Non-aqueous colonic purgative formulations
DE19811167A1 (de) *	1998-03-14	1999-09-16	Findusfit Sportdiaetetika Gmbh	Tablette, Lutschtablette zur Kohlenhydratversorgung mit Langzeitwirkung
AU6044699A (en) *	1998-09-17	2000-04-03	Akesis Pharmaceuticals, Inc.	Compositions and methods for treatment of glucose metabolism disorders
US6376549B1 (en)	1998-09-17	2002-04-23	Akesis Pharmaceuticals, Inc.	Metforimin-containing compositions for the treatment of diabetes
GB0028238D0 (en) *	2000-11-20	2001-01-03	Cerestar Holding Bv	Indigestible oligosaccharides and magnesium absorption in humans
WO2002082928A1 (en) *	2001-04-13	2002-10-24	Joosin R & D Co., Ltd.	Health foods supplementary for treatment and prevention of constipation
US9707253B2 (en) *	2008-05-19	2017-07-18	Pharmalyte Solutions, Llc	High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
CA2903283C (en)	2013-03-15	2023-09-05	Braintree Laboratories, Inc.	Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
EP3338772A1 (de)	2016-12-22	2018-06-27	Merz Pharma GmbH & Co. KGaA	Hydroxycarbonsäure-stabilisierte trimagnesiumdicitratlösungen, deren herstellung und hochkonzentrierte magnesiumlösungen
KR102135463B1 (ko) *	2020-01-23	2020-07-17	주식회사 하이테크글로벌	활성 천연 미네랄을 포함하는 항생제 대체물질

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2816854A (en) *	1953-05-26	1957-12-17	Ralph H Gross	Nutrition aid
US3624201A (en) *	1968-02-12	1971-11-30	Lescarden Ltd	Compositions containing calcium and magnesium salts of citric, phosphoric and lactic acid and method of promoting healing of wounds therewith
ZA715005B (en) *	1970-08-27	1972-04-26	Richardson Merrell Inc	Concentrated antacid composition
US4202887A (en) *	1977-06-27	1980-05-13	Redel, Inc.	Livestock feed supplement
JPS5832857B2 (ja) *	1981-02-23	1983-07-15	南日本酪農協同株式会社	熱凝固性乳蛋白質の製法
US4619829A (en) *	1982-11-16	1986-10-28	Georges Motschan	Utilization of a single vitamin or a combination of various vitamins
EP0174192A3 (en) *	1984-09-05	1987-04-22	Minaminihion Rakuno Kyodo Kabushiki Kaisha	Process for preparing heat resistant milk protein having good processability and/or acid - and base-resistance, and a food product containing such protein
US4582709A (en) *	1985-02-08	1986-04-15	Warner-Lambert Company	Chewable mineral supplement
BE902690A (fr) *	1985-06-18	1985-10-16	Cederroth Nordic Ab	Melange de sels mineraux.
EP0208805A1 (de) *	1985-07-19	1987-01-21	Socop Nahrungsmittel Gmbh	Verfahren zur Herstellung thallophytischer oder bryophytischer Zytorrhysate, danach hergestellte Chemizytorrhysate und deren Verwendung zur Nährstoffergänzung

1987
- 1987-09-28 NO NO874067A patent/NO168563C/no not_active IP Right Cessation
1988
- 1988-09-20 DK DK523388A patent/DK169605B1/da not_active IP Right Cessation
- 1988-09-21 FI FI884326A patent/FI98193C/fi not_active IP Right Cessation
- 1988-09-21 GB GB8822217A patent/GB2210243B/en not_active Expired - Fee Related
- 1988-09-23 US US07/248,419 patent/US4959222A/en not_active Expired - Fee Related
- 1988-09-26 DE DE3832638A patent/DE3832638A1/de active Granted
- 1988-09-27 CN CN88107933A patent/CN1033000A/zh active Pending
- 1988-09-27 LU LU87348A patent/LU87348A1/de unknown
- 1988-09-27 FR FR888812873A patent/FR2620907B1/fr not_active Expired - Fee Related
- 1988-09-27 SE SE8803409A patent/SE501114C2/sv not_active IP Right Cessation
- 1988-09-27 JP JP63239882A patent/JPH01108958A/ja active Granted
- 1988-09-27 ES ES8802928A patent/ES2008604A6/es not_active Expired
- 1988-09-27 IT IT8809491A patent/IT1225239B/it active
- 1988-09-28 KR KR1019880012537A patent/KR920003525B1/ko not_active Expired
- 1988-09-28 NL NL8802383A patent/NL192500C/nl not_active IP Right Cessation
- 1988-09-28 BE BE8801111A patent/BE1003302A3/fr not_active IP Right Cessation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1074265C (zh) *	1999-03-19	2001-11-07	王晓忠	制备冻腐竹的方法
CN100475062C (zh) *	2001-09-19	2009-04-08	丸尾钙株式会社	食品添加剂浆状组合物和粉末组合物、以及含有该食品添加剂组合物的食品组合物

Also Published As

Publication number	Publication date
NO168563B (no)	1991-12-02
IT1225239B (it)	1990-11-02
SE8803409D0 (sv)	1988-09-27
FR2620907A1 (fr)	1989-03-31
NL8802383A (nl)	1989-04-17
FI98193B (fi)	1997-01-31
KR920003525B1 (ko)	1992-05-02
LU87348A1 (de)	1989-04-06
GB2210243B (en)	1991-11-27
DK523388D0 (da)	1988-09-20
NL192500C (nl)	1997-09-02
BE1003302A3 (fr)	1992-02-25
SE501114C2 (sv)	1994-11-21
GB8822217D0 (en)	1988-10-26
US4959222A (en)	1990-09-25
ES2008604A6 (es)	1989-07-16
NO874067D0 (no)	1987-09-28
DK523388A (da)	1989-03-29
NO168563C (no)	1992-03-11
NO874067L (no)	1989-03-29
DE3832638C2 (2)	1991-06-06
DK169605B1 (da)	1994-12-27
KR900004273A (ko)	1990-04-12
FI884326A0 (fi)	1988-09-21
FI884326L (fi)	1989-03-29
DE3832638A1 (de)	1989-04-06
JPH0475748B2 (2)	1992-12-01
SE8803409L (sv)	1989-03-29
IT8809491A0 (it)	1988-09-27
NL192500B (nl)	1997-05-01
GB2210243A (en)	1989-06-07
FR2620907B1 (fr)	1992-11-27
FI98193C (fi)	1997-05-12
JPH01108958A (ja)	1989-04-26

Legal Events

Date	Code	Title
1989-05-24	C06	Publication
1989-05-24	PB01	Publication
1991-07-10	C01	Deemed withdrawal of patent application (patent law 1993)
1991-07-10	WD01	Invention patent application deemed withdrawn after publication

Publication	Publication Date	Title
CN1907094A (zh)	2007-02-07	含乳果冻及其生产方法
CN1076589A (zh)	1993-09-29	营养保健油
CN1223283C (zh)	2005-10-19	提高运动员体能的藻菌食品及其制备方法
CN1390594A (zh)	2003-01-15	改善血液循环的混合物
CN1893841A (zh)	2007-01-10	健康饮料
CN85104754A (zh)	1986-12-10	制酸组成物的制造方法
CN1493319A (zh)	2004-05-05	一种治疗神经衰弱的药物组合物
CN1757290A (zh)	2006-04-12	保健型鱼奶及其加工方法
CN1251268A (zh)	2000-04-26	乳类家畜饲料添加剂
CN1067538C (zh)	2001-06-27	一种保健粉剂
CN1007357B (zh)	1990-03-28	一种蜂蜜发酵酒的制造方法
CN101041024A (zh)	2007-09-26	一种治疗结核病的药物组合物及其制备方法
CN1840171A (zh)	2006-10-04	慢性肾病营养液及其制备方法
CN1806621A (zh)	2006-07-26	一种液态奶
CN1511443A (zh)	2004-07-14	白灵菇的栽培方法及含有白灵菇的疾病预防改善剂
CN1279842C (zh)	2006-10-18	动物脑提取物及提高心理应激适应能力的食物成分组合物
CN1613369A (zh)	2005-05-11	一种多种维生素、矿物质和微量元素复合制剂
CN1568794A (zh)	2005-01-26	一种保健食品及其制备方法以及烘烤装置
KR100793645B1 (ko)	2008-01-10	기능성 사료첨가제
CN1927006A (zh)	2007-03-14	一种营养酵母食品及其制备方法
CN1097560A (zh)	1995-01-25	中、老年人保健用营养性组合物
CN1247211C (zh)	2006-03-29	含灵芝活性物的片状保健品或药品
CN1310948A (zh)	2001-09-05	多功能健康营养液餐
CN1104120A (zh)	1995-06-28	抗衰老降血脂的中药药酒
CN1546087A (zh)	2004-11-17	一种以红景天为主的心脑养护保健品及其制备方法

CN1033000A - 营养品食物和药品的镁添加剂 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=19890268

Family Applications (1)

Country Status (16)

Cited By (2)

Families Citing this family (13)

Family Cites Families (10)

Cited By (2)

Also Published As

Similar Documents

Legal Events